Drug Trial Radar · NCT06539182
DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
Last checked: Nov 19, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
155
Planned (sponsor's estimate)
Start
Apr 29, 2024
Primary completion
Sep 2027
Study completion Mar 2028
Sponsor
- Lead sponsor
- Dizal PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Aug 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will treat patients with CLL/SLL whose disease comes back or is not responding to prior therapy, or if they can not bear side effects of the prior treatment. This study will assess the anti-tumor activity of DZD8586 as monotherapy. It will help to understand what type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body.
Conditions
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Interventions
DZD8586Drug
Daily oral dose of DZD8586 at 25 mg.
DZD8586Drug
Daily oral dose of DZD8586 at 50 mg.
DZD8586Drug
Daily oral dose of DZD8586 at 75 mg.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate assessed by investigatorsTime frame: assessed up to 2 years
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Hefei, Anhui, China · Recruiting
Research Site
Beijing, Beijing Municipality, China · Recruiting
Research Site
Beijing, Beijing Municipality, China · Recruiting
Research Site
Guangzhou, Guandong, China · Recruiting
Research Site
Guangzhou, Guandong, China · Recruiting
Research Site
Zhengzhou, Henan, China · Recruiting
Research Site
Wuhan, Hubei, China · Recruiting
First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Nanjing, Jiangsu, China · Recruiting
Research Site
Changchun, Jilin, China · Recruiting
Research Site
Dalian, Liaoning, China · Not yet recruiting
Research Site
Shenyang, Liaoning, China · Recruiting
Research Site
Jinan, Shandong, China · Recruiting
Research Site
Linyi, Shandong, China · Recruiting
Research Site
Shanghai, Shanghai Municipality, China · Recruiting
Research Site
Taiyuan, Shangxi, China · Recruiting
Research Site
Tianjin, Tianjin Municipality, China · Recruiting
Research Site
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.